Equine Health Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Equine Health Market
The equine health market size was valued at USD 1.84 billion in 2022, and the market is now projected to grow from USD 1.95 billion in 2023 to USD 3.08 billion by 2030, exhibiting a CAGR of 6.7% during the forecast period of 2023-2030.
COVID-19 had a reasonable effect on the worldwide equine market in 2020. The market experienced a deliberate progress trend in 2020 as a consequence of travel limitations and supply chain disturbances. Moreover, the number of veterinary visits to equine farms and ranches declined due to travel limitations and market terminations.
The market is observing strong developments in equine care worldwide. There have been growing initiatives by numerous universities, government agencies, and other charities to upsurge veterinary health awareness. The rising awareness will ultimately augment product implementation, boosting equine health market growth. Thus, augmented alertness regarding veterinary healthcare and precautionary measures is projected to enhance the comprehensive market progression.
Intranasal vaccines are used to vaccinate horses against certain respirational ailments. The intranasal route of administration of the vaccine allows a minor risk of sore muscles and also stimulates local protection. Also, prominent performers augmented emphasis and initiatives on developing advanced products are anticipated to drive the equine health market progression.
Comprehensive Analysis of Equine Health Market
The market can be segmented in various ways, depending on the focus of analysis such as by product, by disease type and by distribution channel. Based on product, the market is classified into drug class, vaccines, and supplemental feed additives. Based on disease type, the market is segmented into west nile virus, equine rabies, equine influenza, equine herpes virus, potomac horse fever, tetanus, and others. Based on distribution channel, the global market is segmented into veterinary hospitals and clinics, retail pharmacies and drug stores, and others.
North America region is dominating the equine health market share due to sturdy equine inhabitants, strong infrastructure, and a rising awareness of numerous equine health product presentations.
The key players are enthusiastically contributing in planned events that are targeted at maintaining durable market position and growing market share by merger, partnerships and others. These players include Zoetis Services LLC (U.S.), Ceva (France), Elanco (U.S.), Boehringer Ingelheim International GmbH (Germany), Vetoquinol (France), Neogen Corporation (U.S.), Virbac (France), Merck & Co., Inc. (U.S.), Norbrook (U.K.), Purina Animal Nutrition LLC. (U.S.), Kyoritsuseiyaku Corporation (Japan), Equine Products UK Ltd. (U.K.) these market players spending severely on research and development in order to arise with more new technology so that they can maintain and improve their existing market.
In May 2023, Merck & Co., Inc. partnered with US Equestrian for progression in animal health through advanced products and technologies.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2030
Base Year 2022
Estimated Year 2023
Forecast Period 2023-2030
Historical Period 2019-2021
Growth Rate CAGR of 6.7% from 2023-2030
Unit Value (USD Billion)
Segmentation By Product
Drug Class
Anti-Infective
Anti-Inflammatory
Parasiticides
Others
Vaccines
Inactivated
Live Attenuated
Recombinant
Others
Supplemental Feed Additives
By Disease Type
West Nile Virus
Equine Rabies
Equine Influenza
Equine Herpes Virus
Potomac Horse Fever
Tetanus
Others
By Distribution Channel
Veterinary Hospitals and Clinics
Retail Pharmacies and Drug Stores
Others
By Region
North America (By Product, Disease Type, Distribution Channel, and Country)
U.S.
Canada
Europe (By Product, Disease Type, Distribution Channel, and Country/Sub-Region)
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Product, Disease Type, Distribution Channel, and Country/Sub-Region)
China
India
Japan
Australia
Southeast Asia
Rest of Asia Pacific
Latin America (By Product, Disease Type, Distribution Channel, and Country/Sub-Region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Product, Disease Type, Distribution Channel, and Country/Sub-Region)
GCC
South Africa
Rest of the Middle East & Africa
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Statistics: Equine Population, By Key Countries, 2022
- 4.2. Regulatory Scenario, Equine Health, By Key Countries, 2022
- 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
- 4.4. Technology Advances in Equine Health
- 4.5. Impact of Covid-19 on the Market
- 5. Global Equine Health Market Analysis, Insights and Forecast, 2019-2030
- 5.1. Market Analysis, Insights and Forecast – By Product
- 5.1.1. Drug Type
- 5.1.1.1. Anti-Infectives
- 5.1.1.2. Anti-Inflammatory
- 5.1.1.3. Parasiticides
- 5.1.1.4. Others
- 5.1.2. Vaccine Type
- 5.1.2.1. Inactivated
- 5.1.2.2. Live Attenuated
- 5.1.2.3. Recombinant
- 5.1.2.4. Others
- 5.1.3. Supplemental Feed Additives
- 5.2. Market Analysis, Insights and Forecast – By Disease Type
- 5.2.1. West Nile Virus
- 5.2.2. Equine Rabies
- 5.2.3. Equine Influenza
- 5.2.4. Equine Herpes Virus
- 5.2.5. Potomac Horse Fever
- 5.2.6. Tetanus
- 5.2.7. Others
- 5.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.3.1. Veterinary Hospitals and Clinics
- 5.3.2. Retail Pharmacies and Drug Stores
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Equine Health Market Analysis, Insights and Forecast, 2019-2030
- 6.1. Market Analysis, Insights and Forecast – By Product
- 6.1.1. Drug Type
- 6.1.1.1. Anti-Infectives
- 6.1.1.2. Anti-Inflammatory
- 6.1.1.3. Parasiticides
- 6.1.1.4. Others
- 6.1.2. Vaccine Type
- 6.1.2.1. Inactivated
- 6.1.2.2. Live Attenuated
- 6.1.2.3. Recombinant
- 6.1.2.4. Others
- 6.1.3. Supplemental Feed Additives
- 6.2. Market Analysis, Insights and Forecast – By Disease Type
- 6.2.1. West Nile Virus
- 6.2.2. Equine Rabies
- 6.2.3. Equine Influenza
- 6.2.4. Equine Herpes Virus
- 6.2.5. Potomac Horse Fever
- 6.2.6. Tetanus
- 6.2.7. Others
- 6.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.3.1. Veterinary Hospitals and Clinics
- 6.3.2. Retail Pharmacies and Drug Stores
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 7. Europe Equine Health Market Analysis, Insights and Forecast, 2019-2030
- 7.1. Market Analysis, Insights and Forecast – By Product
- 7.1.1. Drug Type
- 7.1.1.1. Anti-Infectives
- 7.1.1.2. Anti-Inflammatory
- 7.1.1.3. Parasiticides
- 7.1.1.4. Others
- 7.1.2. Vaccine Type
- 7.1.2.1. Inactivated
- 7.1.2.2. Live Attenuated
- 7.1.2.3. Recombinant
- 7.1.2.4. Others
- 7.1.3. Supplemental Feed Additives
- 7.2. Market Analysis, Insights and Forecast – By Disease Type
- 7.2.1. West Nile Virus
- 7.2.2. Equine Rabies
- 7.2.3. Equine Influenza
- 7.2.4. Equine Herpes Virus
- 7.2.5. Potomac Horse Fever
- 7.2.6. Tetanus
- 7.2.7. Others
- 7.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.3.1. Veterinary Hospitals and Clinics
- 7.3.2. Retail Pharmacies and Drug Stores
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
- 8. Asia Pacific Equine Health Market Analysis, Insights and Forecast, 2019-2030
- 8.1. Market Analysis, Insights and Forecast – By Product
- 8.1.1. Drug Type
- 8.1.1.1. Anti-Infectives
- 8.1.1.2. Anti-Inflammatory
- 8.1.1.3. Parasiticides
- 8.1.1.4. Others
- 8.1.2. Vaccine Type
- 8.1.2.1. Inactivated
- 8.1.2.2. Live Attenuated
- 8.1.2.3. Recombinant
- 8.1.2.4. Others
- 8.1.3. Supplemental Feed Additives
- 8.2. Market Analysis, Insights and Forecast – By Disease Type
- 8.2.1. West Nile Virus
- 8.2.2. Equine Rabies
- 8.2.3. Equine Influenza
- 8.2.4. Equine Herpes Virus
- 8.2.5. Potomac Horse Fever
- 8.2.6. Tetanus
- 8.2.7. Others
- 8.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.3.1. Veterinary Hospitals and Clinics
- 8.3.2. Retail Pharmacies and Drug Stores
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
- 9. Latin America Equine Health Market Analysis, Insights and Forecast, 2019-2030
- 9.1. Market Analysis, Insights and Forecast – By Product
- 9.1.1. Drug Type
- 9.1.1.1. Anti-Infectives
- 9.1.1.2. Anti-Inflammatory
- 9.1.1.3. Parasiticides
- 9.1.1.4. Others
- 9.1.2. Vaccine Type
- 9.1.2.1. Inactivated
- 9.1.2.2. Live Attenuated
- 9.1.2.3. Recombinant
- 9.1.2.4. Others
- 9.1.3. Supplemental Feed Additives
- 9.2. Market Analysis, Insights and Forecast – By Disease Type
- 9.2.1. West Nile Virus
- 9.2.2. Equine Rabies
- 9.2.3. Equine Influenza
- 9.2.4. Equine Herpes Virus
- 9.2.5. Potomac Horse Fever
- 9.2.6. Tetanus
- 9.2.7. Others
- 9.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.3.1. Veterinary Hospitals and Clinics
- 9.3.2. Retail Pharmacies and Drug Stores
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
- 10. Middle East & Africa Equine Health Market Analysis, Insights and Forecast, 2019-2030
- 10.1. Market Analysis, Insights and Forecast – By Product
- 10.1.1. Drug Type
- 10.1.1.1. Anti-Infectives
- 10.1.1.2. Anti-Inflammatory
- 10.1.1.3. Parasiticides
- 10.1.1.4. Others
- 10.1.2. Vaccine Type
- 10.1.2.1. Inactivated
- 10.1.2.2. Live Attenuated
- 10.1.2.3. Recombinant
- 10.1.2.4. Others
- 10.1.3. Supplemental Feed Additives
- 10.2. Market Analysis, Insights and Forecast – By Disease Type
- 10.2.1. West Nile Virus
- 10.2.2. Equine Rabies
- 10.2.3. Equine Influenza
- 10.2.4. Equine Herpes Virus
- 10.2.5. Potomac Horse Fever
- 10.2.6. Tetanus
- 10.2.7. Others
- 10.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 10.3.1. Veterinary Hospitals and Clinics
- 10.3.2. Retail Pharmacies and Drug Stores
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2022)
- 11.2. Company Profiles
- 11.2.1. Zoetis Services LLC
- 11.2.1.1. Overview
- 11.2.1.2. Product
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. financials (Based on Availability)
- 11.2.2. Ceva
- 11.2.2.1. Overview
- 11.2.2.2. Product
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. financials (Based on Availability)
- 11.2.3. Elanco
- 11.2.3.1. Overview
- 11.2.3.2. Product
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. financials (Based on Availability)
- 11.2.4. Boehringer Ingelheim International GmbH
- 11.2.4.1. Overview
- 11.2.4.2. Product
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. financials (Based on Availability)
- 11.2.5. Vetoquinol
- 11.2.5.1. Overview
- 11.2.5.2. Product
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. financials (Based on Availability)
- 11.2.6. Neogen Corporation
- 11.2.6.1. Overview
- 11.2.6.2. Product
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. financials (Based on Availability)
- 11.2.7. Virbac
- 11.2.7.1. Overview
- 11.2.7.2. Product
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. financials (Based on Availability)
- 11.2.8. Merck & Co., Inc.
- 11.2.8.1. Overview
- 11.2.8.2. Product
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. financials (Based on Availability)
- 11.2.9. Norbrook
- 11.2.9.1. Overview
- 11.2.9.2. Product
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. financials (Based on Availability)
- 11.2.10. Purina Animal Nutrition LLC.
- 11.2.10.1. Overview
- 11.2.10.2. Product
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. financials (Based on Availability)
- 11.2.11. Kyoritsuseiyaku Corporation
- 11.2.11.1. Overview
- 11.2.11.2. Product
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Strategies
- 11.2.11.6. financials (Based on Availability)
- 11.2.12. Equine Products UK Ltd.
- 11.2.12.1. Overview
- 11.2.12.2. Product
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Strategies
- 11.2.12.6. financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook